LAURA CRITES: Open Payments
NPI 1780272591 · SAN DIEGO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,121 in 23 payments from 13 companies in 2025. Trend: 2023 $1,044 · 2024 $1,427 · 2025 $1,121
Food & beverage: $1,121
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 3 | $284 |
| Organon LLC | 1 | $141 |
| HEARTFLOW, INC. | 1 | $125 |
| Axsome Therapeutics, Inc. | 1 | $110 |
| Exact Sciences Corporation | 3 | $89 |
| PFIZER INC. | 3 | $86 |
| Lilly USA, LLC | 3 | $83 |
| Gilead Sciences, Inc. | 2 | $54 |
| Boston Scientific Corporation | 1 | $45 |
| ViiV Healthcare Company | 2 | $44 |
Products named: AIRSUPRA, VTAMA, FFRct, Auvelity, Cologuard Collection Kit, PREVNAR 20, MOUNJARO, WaveWriter Alpha Prime 16.
Industry payments across CA — which companies pay providers there.
